$GHDX GENOMIC HEALTH INC Insider Trading Week 48/2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in GENOMIC HEALTH INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in GENOMIC HEALTH INC in week 48/2018.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 07 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.15 | 84,418 | 6,428,768 | 9,754,128 | 9.8 M to 9.8 M (-0.86 %) |
| Dec 07 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.15 | 12,961 | 987,032 | 1,531,758 | 1.5 M to 1.5 M (-0.84 %) |
| Dec 07 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.15 | 2,234 | 170,128 | 297,486 | 299.7 K to 297.5 K (-0.75 %) |
| Dec 07 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.15 | 1,296 | 98,696 | 189,504 | 190.8 K to 189.5 K (-0.68 %) |
| Dec 07 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.15 | 99 | 7,539 | 51,769 | 51.9 K to 51.8 K (-0.19 %) |
| Dec 07 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.15 | 1,447 | 110,195 | 206,880 | 208.3 K to 206.9 K (-0.69 %) |
| Dec 07 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 75.46 | 76,364 | 5,762,481 | 9,838,546 | 9.9 M to 9.8 M (-0.77 %) |
| Dec 07 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 75.46 | 11,724 | 884,701 | 1,544,719 | 1.6 M to 1.5 M (-0.75 %) |
| Dec 07 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 75.46 | 2,021 | 152,506 | 299,720 | 301.7 K to 299.7 K (-0.67 %) |
| Dec 07 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 75.46 | 1,172 | 88,440 | 190,800 | 192 K to 190.8 K (-0.61 %) |
| Dec 07 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 75.46 | 89 | 6,716 | 51,868 | 52 K to 51.9 K (-0.17 %) |
| Dec 07 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 75.46 | 1,309 | 98,778 | 208,327 | 209.6 K to 208.3 K (-0.62 %) |
| Dec 07 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 77.75 | 2,538 | 197,318 | 9,914,910 | 9.9 M to 9.9 M (-0.03 %) |
| Dec 07 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 77.75 | 390 | 30,321 | 1,556,443 | 1.6 M to 1.6 M (-0.03 %) |
| Dec 07 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 77.75 | 67 | 5,209 | 301,741 | 301.8 K to 301.7 K (-0.02 %) |
| Dec 07 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 77.75 | 39 | 3,032 | 191,972 | 192 K to 192 K (-0.02 %) |
| Dec 07 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 77.75 | 3 | 233 | 51,957 | 52 K to 52 K (-0.01 %) |
| Dec 07 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 77.75 | 43 | 3,343 | 209,636 | 209.7 K to 209.6 K (-0.02 %) |
| Dec 07 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 73.81 | 5,493 | 405,449 | 9,917,448 | 9.9 M to 9.9 M (-0.06 %) |
| Dec 07 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 73.81 | 843 | 62,223 | 1,556,833 | 1.6 M to 1.6 M (-0.05 %) |
| Dec 07 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 73.81 | 146 | 10,777 | 301,808 | 302 K to 301.8 K (-0.05 %) |
| Dec 07 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 73.81 | 84 | 6,200 | 192,011 | 192.1 K to 192 K (-0.04 %) |
| Dec 07 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 73.81 | 6 | 443 | 51,960 | 52 K to 52 K (-0.01 %) |
| Dec 07 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 73.81 | 95 | 7,012 | 209,679 | 209.8 K to 209.7 K (-0.05 %) |
| Dec 07 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 75.83 | 18,604 | 1,410,758 | 9,922,941 | 9.9 M to 9.9 M (-0.19 %) |
| Dec 07 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 75.83 | 2,856 | 216,573 | 1,557,676 | 1.6 M to 1.6 M (-0.18 %) |
| Dec 07 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 75.83 | 492 | 37,309 | 301,954 | 302.4 K to 302 K (-0.16 %) |
| Dec 07 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 75.83 | 286 | 21,688 | 192,095 | 192.4 K to 192.1 K (-0.15 %) |
| Dec 07 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 75.83 | 21 | 1,592 | 51,966 | 52 K to 52 K (-0.04 %) |
| Dec 07 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 75.83 | 319 | 24,190 | 209,774 | 210.1 K to 209.8 K (-0.15 %) |
| Dec 07 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 77.11 | 371 | 28,608 | 9,941,545 | 9.9 M to 9.9 M (0.00 %) |
| Dec 07 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 77.11 | 57 | 4,395 | 1,560,532 | 1.6 M to 1.6 M (0.00 %) |
| Dec 07 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 77.11 | 10 | 771 | 302,446 | 302.5 K to 302.4 K (0.00 %) |
| Dec 07 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 77.11 | 6 | 463 | 192,381 | 192.4 K to 192.4 K (0.00 %) |
| Dec 07 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 77.11 | 1 | 77 | 51,987 | 52 K to 52 K (0.00 %) |
| Dec 07 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 77.11 | 6 | 463 | 210,093 | 210.1 K to 210.1 K (0.00 %) |
| Dec 07 2018 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Option Exercise | M | 31.12 | 3,000 | 93,360 | 33,772 | |
| Dec 07 2018 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Sell | S | 75.72 | 1,104 | 83,595 | 17,763 | 18.9 K to 17.8 K (-5.85 %) |
| Dec 07 2018 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Sell | S | 75.29 | 1,596 | 120,168 | 18,867 | 20.5 K to 18.9 K (-7.80 %) |
| Dec 07 2018 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Sell | S | 73.75 | 300 | 22,126 | 20,463 | 20.8 K to 20.5 K (-1.44 %) |
| Dec 07 2018 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Buy | M | 31.12 | 3,000 | 93,360 | 20,763 | 17.8 K to 20.8 K (+16.89 %) |
| Dec 06 2018 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Option Exercise | M | 17.33 | 1,500 | 25,995 | 0 | |
| Dec 06 2018 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Sell | S | 80.40 | 200 | 16,079 | 336,741 | 336.9 K to 336.7 K (-0.06 %) |
| Dec 06 2018 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Sell | S | 78.60 | 100 | 7,860 | 336,941 | 337 K to 336.9 K (-0.03 %) |
| Dec 06 2018 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Sell | S | 77.93 | 1,087 | 84,715 | 337,041 | 338.1 K to 337 K (-0.32 %) |
| Dec 06 2018 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Sell | S | 76.28 | 113 | 8,619 | 338,128 | 338.2 K to 338.1 K (-0.03 %) |
| Dec 06 2018 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Buy | M | 17.33 | 1,500 | 25,995 | 338,241 | 336.7 K to 338.2 K (+0.45 %) |
| Dec 03 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.62 | 247 | 18,925 | 9,941,916 | 9.9 M to 9.9 M (0.00 %) |
| Dec 03 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.62 | 38 | 2,911 | 1,560,589 | 1.6 M to 1.6 M (0.00 %) |
| Dec 03 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.62 | 6 | 460 | 302,456 | 302.5 K to 302.5 K (0.00 %) |
| Dec 03 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.62 | 4 | 306 | 192,387 | 192.4 K to 192.4 K (0.00 %) |
| Dec 03 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.62 | 1 | 77 | 51,988 | 52 K to 52 K (0.00 %) |
| Dec 03 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.62 | 4 | 306 | 210,099 | 210.1 K to 210.1 K (0.00 %) |
| Dec 03 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 77.52 | 32,598 | 2,527,147 | 9,942,163 | 10 M to 9.9 M (-0.33 %) |
| Dec 03 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 77.52 | 5,005 | 388,011 | 1,560,627 | 1.6 M to 1.6 M (-0.32 %) |
| Dec 03 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 77.52 | 863 | 66,904 | 302,462 | 303.3 K to 302.5 K (-0.28 %) |
| Dec 03 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 77.52 | 500 | 38,762 | 192,391 | 192.9 K to 192.4 K (-0.26 %) |
| Dec 03 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 77.52 | 38 | 2,946 | 51,989 | 52 K to 52 K (-0.07 %) |
| Dec 03 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 77.52 | 559 | 43,336 | 210,103 | 210.7 K to 210.1 K (-0.27 %) |
| Dec 03 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 78.05 | 89,047 | 6,950,074 | 9,974,761 | 10.1 M to 10 M (-0.88 %) |
| Dec 03 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 78.05 | 13,671 | 1,067,015 | 1,565,632 | 1.6 M to 1.6 M (-0.87 %) |
| Dec 03 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 78.05 | 2,357 | 183,963 | 303,325 | 305.7 K to 303.3 K (-0.77 %) |
| Dec 03 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 78.05 | 1,367 | 106,694 | 192,891 | 194.3 K to 192.9 K (-0.70 %) |
| Dec 03 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 78.05 | 104 | 8,117 | 52,027 | 52.1 K to 52 K (-0.20 %) |
| Dec 03 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 78.05 | 1,526 | 119,104 | 210,662 | 212.2 K to 210.7 K (-0.72 %) |
| Dec 03 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 80.09 | 44,659 | 3,576,721 | 10,063,808 | 10.1 M to 10.1 M (-0.44 %) |
| Dec 03 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 80.09 | 6,856 | 549,094 | 1,579,303 | 1.6 M to 1.6 M (-0.43 %) |
| Dec 03 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 80.09 | 1,182 | 94,666 | 305,682 | 306.9 K to 305.7 K (-0.39 %) |
| Dec 03 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 80.09 | 685 | 54,861 | 194,258 | 194.9 K to 194.3 K (-0.35 %) |
| Dec 03 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 80.09 | 52 | 4,165 | 52,131 | 52.2 K to 52.1 K (-0.10 %) |
| Dec 03 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 80.09 | 765 | 61,269 | 212,188 | 213 K to 212.2 K (-0.36 %) |
| Dec 03 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 79.07 | 129,121 | 10,209,675 | 10,108,467 | 10.2 M to 10.1 M (-1.26 %) |
| Dec 03 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 79.07 | 19,824 | 1,567,496 | 1,586,159 | 1.6 M to 1.6 M (-1.23 %) |
| Dec 03 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 79.07 | 3,417 | 270,184 | 306,864 | 310.3 K to 306.9 K (-1.10 %) |
| Dec 03 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 79.07 | 1,981 | 156,639 | 194,943 | 196.9 K to 194.9 K (-1.01 %) |
| Dec 03 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 79.07 | 151 | 11,940 | 52,183 | 52.3 K to 52.2 K (-0.29 %) |
| Dec 03 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 79.07 | 2,214 | 175,062 | 212,953 | 215.2 K to 213 K (-1.03 %) |
| Dec 03 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 79.63 | 39,591 | 3,152,536 | 10,237,588 | 10.3 M to 10.2 M (-0.39 %) |
| Dec 03 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 79.63 | 6,078 | 483,977 | 1,605,983 | 1.6 M to 1.6 M (-0.38 %) |
| Dec 03 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 79.63 | 1,048 | 83,450 | 310,281 | 311.3 K to 310.3 K (-0.34 %) |
| Dec 03 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 79.63 | 608 | 48,414 | 196,924 | 197.5 K to 196.9 K (-0.31 %) |
| Dec 03 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 79.63 | 46 | 3,663 | 52,334 | 52.4 K to 52.3 K (-0.09 %) |
| Dec 03 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 79.63 | 678 | 53,988 | 215,167 | 215.8 K to 215.2 K (-0.31 %) |
| Dec 03 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 77.61 | 30,257 | 2,348,376 | 10,277,179 | 10.3 M to 10.3 M (-0.29 %) |
| Dec 03 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 77.61 | 4,646 | 360,596 | 1,612,061 | 1.6 M to 1.6 M (-0.29 %) |
| Dec 03 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 77.61 | 801 | 62,169 | 311,329 | 312.1 K to 311.3 K (-0.26 %) |
| Dec 03 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 77.61 | 465 | 36,091 | 197,532 | 198 K to 197.5 K (-0.23 %) |
| Dec 03 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 77.61 | 35 | 2,717 | 52,380 | 52.4 K to 52.4 K (-0.07 %) |
| Dec 03 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 77.61 | 518 | 40,204 | 215,845 | 216.4 K to 215.8 K (-0.24 %) |
| Dec 03 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 78.80 | 11,994 | 945,149 | 10,307,436 | 10.3 M to 10.3 M (-0.12 %) |
| Dec 03 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 78.80 | 1,841 | 145,074 | 1,616,707 | 1.6 M to 1.6 M (-0.11 %) |
| Dec 03 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 78.80 | 317 | 24,980 | 312,130 | 312.4 K to 312.1 K (-0.10 %) |
| Dec 03 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 78.80 | 184 | 14,500 | 197,997 | 198.2 K to 198 K (-0.09 %) |
| Dec 03 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 78.80 | 14 | 1,103 | 52,415 | 52.4 K to 52.4 K (-0.03 %) |
| Dec 03 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 78.80 | 206 | 16,233 | 216,363 | 216.6 K to 216.4 K (-0.10 %) |